CHASE WILLIAM J - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 12, 2024, CHASE WILLIAM J's relationship to Intellia Therapeutics, Inc. (NTLA) is Director, and currently has 26,693 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NTLA insiders.
Data Source: SEC.
CHASE WILLIAM J - Insider Non-Derivative Transactions of NTLA Common Stock
CHASE WILLIAM J - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 13, 2024 | Acquisition -- (Common Stock) | 7737 | 0 | 26693 |
| Jun 15, 2023 | Acquisition -- (Common Stock) | 1673 | 0 | 18956 |
| Apr 15, 2023 | Acquisition -- (Common Stock) | 10483 | 0 | 17283 |